SEARCH

SEARCH BY CITATION

References

  • 1
    Knowles WA. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: KhaliliK, StonerGL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York : Wiley–Liss, 2001: 527559.
  • 2
    Mackenzie EF, Poulding JM, Harrison PR, Amer B. Human polyoma virus (HPV)—a significant pathogen in renal transplantation. Proc Eur Dial Transplant Assoc 1978; 15: 352360.
  • 3
    Gardner SD, Mackenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578586.
  • 4
    Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373378.
  • 5
    Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488496.DOI: 10.1056/NEJMoa020439
  • 6
    Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 13091315.DOI: 10.1056/NEJM200005043421802
  • 7
    Ramos E, Drachenberg CB, Portocarrero M et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002; 143153.
  • 8
    Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 21452151.DOI: 10.1097/01.ASN.0000023435.07320.81
  • 9
    Buehrig CK, Lager DJ, Stegall MD et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665673.
  • 10
    Ahuja M, Cohen EP, Dayer AM et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896899.DOI: 10.1097/00007890-200104150-00013
  • 11
    Mengel M, Marwedel M, Radermacher J et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 11901196.DOI: 10.1093/ndt/gfg072
  • 12
    Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 12531257.DOI: 10.1016/S0140-6736(71)91776-4
  • 13
    Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103109.DOI: 10.1097/00007890-199901150-00018
  • 14
    Barri YM, Ahmad I, Ketel BL et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. Clin Transplant 2001; 15: 240246.
  • 15
    Arthur RR, Dagostin S, Shah KV. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol 1989; 27: 11741179.
  • 16
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.DOI: 10.1046/j.1523-1755.1999.00299.x
  • 17
    Remuzzi G, Lesti M, Gotti E et al. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Lancet 2004; 364: 50312.DOI: 10.1016/S0140-6736(04)16808-6
  • 18
    Gerbase MW, Fathi M, Spiliopoulos A, Rochat T, Nicod LP. Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: long-term monitoring in stable lung recipients with and without cystic fibrosis. J Heart Lung Transplant 2003; 22: 587590.DOI: 10.1016/S1053-2498(02)01159-2